About

We are a cell therapy company developing a new class of treatments and potential cures for serious autoimmune diseases.

Autoimmune diseases result from a failure of the immune system to distinguish self from non-self, caused by autoreactive B cells and T cells attacking the body’s own tissues. Kyverna’s therapeutic strategy combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate these autoreactive immune cells at the root cause of inflammatory disease.

Backed by experienced investors with a track record of success in biotechnology and cell therapy.

Westlake Village Biopartners

Vida Ventures

Gilead

JOIN OUR TEAM OF MISSION-DRIVEN SCIENTISTS AND PROFESSIONALS
developing groundbreaking new therapies for patients with autoimmune diseases.

CAREERS